Anakinra, una alternativa potencial en el tratamiento de la infección respiratoria grave por SARS-CoV-2 refractaria a tocilizumab: comentario / Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: coment
Reumatol. clín. (Barc.)
; 19(2): 120-121, Feb. 2023.
Article
in Es
| IBECS
| ID: ibc-215757
Responsible library:
ES1.1
Localization: ES15.1 - BNCS
Search on Google
Collection:
06-national
/
ES
Database:
IBECS
Main subject:
Respiratory Insufficiency
/
Respiratory Tract Infections
/
Coronavirus Infections
/
Severe acute respiratory syndrome-related coronavirus
/
Pandemics
Limits:
Humans
Language:
Es
Journal:
Reumatol. clín. (Barc.)
Year:
2023
Document type:
Article